UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy

Head & neck, 2020-08, Vol.42 (8), p.2030-2038

2020

Volltextzugriff (PDF)

Real‐world treatment patterns of metastatic non‐small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.159-169

2023

Volltextzugriff (PDF)

Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13415-13425

2023

Volltextzugriff (PDF)

Race and medication adherence in medicaid enrollees with type-2 diabetes

Journal of the National Medical Association, 2006-07, Vol.98 (7), p.1071-1077

2006

Volltextzugriff (PDF)

How patient-physician encounters in critical medical situations affect trust: results of a national survey

BMC health services research, 2004-09, Vol.4 (1), p.24-24, Article 24

2004

Volltextzugriff (PDF)

Effect of Exposure to Evidence-Based Pharmacotherapy on Outcomes After Acute Myocardial Infarction in Older Adults

Journal of the American Geriatrics Society (JAGS), 2012-10, Vol.60 (10), p.1854-1861

2012

Volltextzugriff (PDF)

Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States

Gynecologic oncology, 2018-11, Vol.151 (2), p.190-195

2018

Volltextzugriff (PDF)

EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Cancer treatment and research communications, 2021, Vol.27, p.100327-100327, Article 100327

2021

Volltextzugriff (PDF)

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.289-289

2021

Volltextzugriff (PDF)

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.402-402

2022

Volltextzugriff (PDF)

Employee Health and Frequency of Workers' Compensation and Disability Claims

Journal of occupational and environmental medicine, 2009-09, Vol.51 (9), p.1041-1048

2009

Volltextzugriff (PDF)

Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus

Clinical therapeutics, 2007-01, Vol.29 (6), p.1306-1315

2007

Volltextzugriff (PDF)

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.102-102

2018

Volltextzugriff (PDF)

Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive : An analysis of data from the national ambulatory medical care survey for 1996-2001

Clinical therapeutics, 2005-12, Vol.27 (12), p.1970-1979

2005

Volltextzugriff (PDF)

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.415-415

2018

Volltextzugriff (PDF)

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5574-5574

2017

Volltextzugriff (PDF)

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.281-281

2020

Volltextzugriff (PDF)

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.363-363

2019

Volltextzugriff (PDF)

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19345-e19345

2020

Volltextzugriff (PDF)

Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors

Journal of the National Comprehensive Cancer Network, 2024-01, Vol.22 (1D), p.e237072

2024

Volltextzugriff (PDF)

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16032-e16032

2017

Volltextzugriff (PDF)

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.396-396

2017

Volltextzugriff (PDF)

Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA

Future oncology (London, England), 2019-11, Vol.15 (33), p.3809-3818

2019

Volltextzugriff (PDF)

A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children

The Pediatric infectious disease journal, 2017-12, Vol.36 (12), p.1129-1140

2017

Volltextzugriff (PDF)

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

Clinical genitourinary cancer, 2018-12, Vol.16 (6), p.e1171-e1179

2018

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaPatient Compliance

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(50)
Dissertationen
(1)

Sprache

Englisch
(51)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Real‐world treatment patterns for patients with metastatic head and neck squamous cell carcinoma treated with immuno‐oncology therapy

Real‐world treatment patterns of metastatic non‐small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors

Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting

Race and medication adherence in medicaid enrollees with type-2 diabetes

How patient-physician encounters in critical medical situations affect trust: results of a national survey

Effect of Exposure to Evidence-Based Pharmacotherapy on Outcomes After Acute Myocardial Infarction in Older Adults

Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States

EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer

Real-world treatment patterns of metastatic non-small cell lung cancer (mNSCLC) patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)

Real-world utilization of liquid biopsy for epidermal growth factor receptor (EGFR) testing in patients with metastatic non-small cell lung cancer (mNSCLC)

Employee Health and Frequency of Workers' Compensation and Disability Claims

Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus

Impact of Oncology Care Model (OCM) on episode costs and performance revenues: Considerations for oncology practices

Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive : An analysis of data from the national ambulatory medical care survey for 1996-2001

Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma

Incidence of secondary myelodysplastic syndrome and acute myeloid leukemia in patients with ovarian and breast cancer in real-world setting in the U.S

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Economic burden of select adverse events (AEs) in patients (Pts) with advanced urothelial cancer (aUC) treated with first-line (1L) systemic therapy

Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting

Lung Cancer Survivorship: Physical, Social, Emotional, and Medical Needs of NSCLC Survivors

Health resource utilization and costs for stage IV bladder cancer in community oncology settings

Treatment patterns and outcomes in metastatic bladder cancer in community oncology settings

Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA

A Retrospective Cohort Study of the Incidence, Health Care Resource Utilization and Costs of International Classification of Diseases, Clinical Modification, 9th Revision Diagnosed Influenza and Related Complications in US Children

Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015

Aktive Filter

Suchergebnisse filtern